 suppress express papillari endothelium psoriat plaqu mode action cyclosporin csa psoriasi phenotyp profil resid passeng skin cell psoriat patient week csa treatment larg panel monoclon antibodi three-step immunoperoxidas techniqu comparison skin biopsi psoriat patient psoralen uva puva therapi treatment protocol effect resolut psoriat lesion phenotyp chang csa puva csa-treat patient dramat reduct express papillari endotheli cell densiti pattern phenotyp inflammatori cell unchang contrast puva therapi visibl effect express papillari endotheli cell signific reduct hemopoiet resid mononuclear cell epidermi result assumpt csa regimen studi anti-psoriat effect level keratinocyt event prolifer secret mediat respons express papillari endotheli cell